Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Straumann Holding    STMN   CH0012280076

STRAUMANN HOLDING (STMN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summaryMarketScreener Strategies

Ulrich Ebensperger

Financial Analyst
 
share with twitter share with LinkedIn share with facebook
share via e-mail

The technical configuration is positive

Strategy published on 10/11/2018 | 09:37
long trade
Live
Entry price : 652.5CHF | Target : 809.5CHF | Stop-loss : 610CHF | Potential : 24.06%
Shares in Straumann Holding show a positive technical chart pattern over the medium term. The timing to jump back on the rising trend seems good.
Investors have an opportunity to buy the stock and target the CHF 809.5.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • The close medium term support offers good timing for purchasing the stock.
  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses
  • Based on current prices, the company has particularly high valuation levels.
  • With an expected P/E ratio at 37.29 and 30.18 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Subsector Medical Equipment, Supplies & Distribution
1st jan.Capitalisation (M$)Investor Rating
STRAUMANN HOLDING-3.92%10 880
MEDTRONIC PLC17.26%129 541
ABBOTT LABORATORIES21.48%119 539
STRYKER CORPORATION10.46%64 738
BECTON, DICKINSON AND COMPA..13.34%64 162
ESSILORLUXOTTICA-0.44%47 680
BAXTER INTERNATIONAL10.23%37 650
ALIGN TECHNOLOGY42.86%25 948
ZIMMER BIOMET HOLDINGS2.35%25 704
TERUMO CORP20.63%21 976
HOYA CORPORATION10.94%21 754
Autres valeurs du secteur
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (CHF)
Sales 2018 1 342 M
EBIT 2018 345 M
Net income 2018 282 M
Finance 2018 159 M
Yield 2018 0,77%
P/E ratio 2018 38,73
P/E ratio 2019 31,35
EV / Sales 2018 7,98x
EV / Sales 2019 6,88x
Capitalization 10 861 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart STRAUMANN HOLDING
Duration : Period : Day
Straumann Holding Technical Analysis Chart | MarketScreener
Duration : Period : Week
Straumann Holding Technical Analysis Chart | MarketScreener